Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Celgene Corporation
Celgene Corporation_20100121
  

Celgene Corporation patents

Recent patent applications related to Celgene Corporation. Celgene Corporation is listed as an Agent/Assignee. Note: Celgene Corporation may have other listings under different names/spellings. We're not affiliated with Celgene Corporation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Celgene Corporation-related inventors




Date Celgene Corporation patents (updated weekly) - BOOKMARK this page
08/17/17 new patent  Combination therapy for treating cancer
08/17/17 new patent  Methods for dosing and monitoring smad7 antisense oligonucleotide treatment using biomarker levels
07/13/17Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
07/13/17Antiproliferative compounds, and their pharmaceutical compositions and uses
07/13/17Solid forms of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
07/13/17Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
06/22/173-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
06/15/17Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
06/08/17Methods of treating diffuse large b-cell lymphoma using 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
06/08/17Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
05/25/17Apremilast for the treatment of a liver disease or a liver function abnormality
05/11/17Combination therapy for cancer
05/11/17Processes for the preparation of (s)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
05/11/176-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
05/04/17Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/04/17Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/04/17Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
04/27/17Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
04/06/17Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
03/30/17Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators
03/30/17Isoindoline compounds and methods of their use
03/30/17Pd-1 binding proteins and methods of use thereof
03/30/17Methods for treating diffuse large b-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs
03/02/17Formulations of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
02/09/17Methods for treating chronic lymphocytic leukemia and the use of biomarkers as a predictor of clinical sensitivity to immunomodulatory therapies
02/02/17Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
01/12/17Antiproliferative compounds and methods of use thereof
01/12/17Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
01/12/17Romidepsin formulations and uses thereof
01/05/17Modulation of stem cell and progenitor cell differentiation, assays, and uses thereof
01/05/17Romidepsin formulations and uses thereof
12/29/16Methods for the treatment of kaposi's sarcoma or kshv-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
12/22/16Romidepsin formulations and uses thereof
12/08/16Methods for determining drug efficacy for treatment of cancer using ratios of cereblon associated proteins
12/01/165-substituted isoindoline compounds
11/03/16Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
10/27/16Methods for treating hematological cancers and the use of biomarkers as a predictor of clinical sensitivity to immunodulatory therapies
10/27/16Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers
10/13/16Solid forms comprising 4-amino-i-b-d-ribofuranosyl-1,3,5-triazin-2 (1h) -one and a coformer, compositions and methods of use thereof
10/13/16Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
10/06/16Compositions and methods for the treatment of viral diseases with pde4 modulators
09/15/16Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
09/08/16Methods of treating cancer using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
09/01/16Oral formulations of cytidine analogs and methods of use thereof
09/01/16Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
07/28/16Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
07/21/16Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
06/09/16Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
06/09/16Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
06/02/16Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
06/02/16Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphoma
05/19/16Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
05/19/16Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
05/12/16Controlled release oral dosage forms of poorly soluble drugs and uses thereof
04/28/16Isoindoline compounds and methods of their use
04/07/16Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and reducing tnfalpha levels
03/10/16Romidepsin formulations and uses thereof
03/10/16Romidepsin formulations and uses thereof
03/10/16Methods for treating a disease or disorder using oral formulations of cytidine analogs in combination with an anti-pd1 or anti-pdl1 monoclonal antibody
03/03/16Romidepsin solid forms and uses thereof
02/25/16Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
02/18/16Methods for the treatment of diseases ameliorated by pde4 inhibition using dosage titration of apremilast
02/18/16Solid forms comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof
02/18/16Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers
02/11/16Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
Patent Packs
02/04/16Resistance biomarkers for hdac inhibitors
02/04/16Processes for the preparation of (s)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
01/28/164'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
01/21/16Engager cells for immunotherapy
01/14/16Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor
01/14/16Methods for treating gliomas with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
01/14/16Antiproliferative compounds and methods of use thereof
01/14/16Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
01/14/16Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
12/31/15Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
12/31/15Oral formulations of cytidine analogs and methods of use thereof
12/24/15Inhibition of drug resistant cancer cells
12/17/15Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
12/17/15Processes for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
11/19/15Use of pde4 inhibitors and combinations thereof for the treatment of cystic fibrosis
Patent Packs
11/19/15Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment of cancers
10/22/15Treatment of cancer with pomalidomide in a renally impaired subject
10/15/15Methods for the treatment of bone loss
10/15/156-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
10/08/15Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells
10/08/15Activin-actrii antagonists and uses for treating bone and other disorders
10/01/15Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
10/01/15Biomarker for use in treating anemia
09/24/15Nanosuspension of a poorly soluble drug via microfluidization process
09/24/15Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
09/24/15Methods for treating anemia
09/17/15Isotopologues of isoindole derivatives
08/20/15Combination therapy for hematological malignancies
08/20/15Pharmaceutical composition containing core factor involved in proliferation and differentiation of central nervous cell
08/13/15Methods for the treatment of locally advanced breast cancer
08/06/15Methods for treating cancers using oral formulations of cytidine analogs
08/06/15Romidepsin solid forms and uses thereof
07/30/15Methods for the treatment of obesity using apremilast
07/23/15Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
07/16/15Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
07/16/15Formulations of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
07/09/15Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl) piperidine-2,6-dione in combination with second active agents
07/09/15Systems and methods for providing a stem cell bank
07/02/15Romidepsin formulations and uses thereof
07/02/15Deacetylase inhibitor therapy
07/02/15Processes for the preparation of isoindole compounds and isotopologues thereof
06/25/15Methods for the treatment of psoriatic arthritis using apremilast
06/25/15Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor
06/04/15Cereblon isoforms and their use as biomarkers for therapeutic treatment
05/07/15Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
Social Network Patent Pack
04/09/15Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
04/02/15Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
04/02/15Methods for treating gliomas with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
04/02/15Solid forms of 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
03/19/155-substituted quinazolinone derivatives and compositions comprising and methods of using the same
02/26/15Isotopologues of 5-azacytidine
02/19/15Romidepsin formulations and uses thereof
02/05/15Treating myelodysplastic syndromes using lenalidomide
02/05/15Treatment of immune-related and inflammatory diseases
01/01/155-substituted isoindoline compounds
Patent Packs
12/25/14Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone
12/25/14Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
12/18/14Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
12/18/14Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-ethylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
11/06/14Methods for treating cancer using combination therapy
11/06/14Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
10/16/14Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
10/09/14Methods for the treatment of psoriatic arthritis using apremilast
09/18/14Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
09/11/14Romidepsin solid forms and uses thereof
09/11/14Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
08/07/14Isotopologues of pomalidomide
07/24/14Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
07/24/14Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
07/10/14Isotopologues of isoindole derivatives
07/03/14Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
07/03/14Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and reducing tnfalpha levels
07/03/14Methods for treating diseases using isoindoline compounds
06/12/14Methods for determining drug efficacy using cereblon-associated proteins
05/29/14Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
05/22/14Inhibition of drug resistant cancer cells
04/24/14Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
04/24/14N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
04/17/14Biomarkers for the treatment of multiple myeloma
04/10/14Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
04/03/14Oral dosage forms of cyclopropanecarboxylic acid -amide
03/20/14Processes for the preparation of isoindole compounds and isotopologues thereof
03/13/14Resistance biomarkers for hdac inhibitors
02/13/14Methods of treating cancer using 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
02/13/14Treatment of immune-related and inflammatory diseases
Patent Packs
02/13/14Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
02/13/14Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
01/30/14Combination therapy with lenalidomide and a cdk inhibitor for treating multiple myeloma
01/30/14Processes for preparing isoindoline-1,3-dione compounds
01/23/14Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
01/16/14Controlled release oral dosage forms of poorly soluble drugs and uses thereof
01/02/14Gemcitabine combination therapy
12/05/13Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
10/31/136-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
10/17/13Methods for treating non-small cell lung cancer using 5-azacytidine
09/19/13Combination therapy for chemoresistant cancers
09/12/13Romidepsin-based treatments for cancer
09/05/13Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
08/22/13Processes for the preparation of (s)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine
08/22/13Asymmetric synthetic processes for the preparation of aminosulfone compounds
08/08/13Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
07/18/13Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor
07/18/13Biomarkers for the treatment of hepatocellular carcinoma
07/11/13Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
07/11/13Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
Social Network Patent Pack
07/04/13Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells
06/27/13Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione
05/30/13Methods for treating respiratory viral infection
05/16/13Methods for increasing levels of human fetal hemoglobin
05/09/13(methylsulfonyl) ethyl benzene isoindoline derivatives and their pharmaceutical uses
05/02/13Methods for treating cancers using oral formulations of cytidine analogs
04/04/13Combination therapy for lymphoma
02/21/13Isoindoline compounds and methods of their use
01/31/13Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and reducing tnfalpha levels
11/29/12Gemcitabine combination therapy
08/02/12Pharmaceutical compositions of cytidine analogs and methods of use thereof
07/26/12Romidepsin solid forms and uses thereof
07/12/12Phenethylsulfone isoindoline derivatives and their use
06/28/12Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-(is)-(3-ethoxy-4methoxy-phenyl)-2-methanesulfonyl-ethyl}-3-oxo-2.3-dihydro-1h-isoindol-4-yl}-amide
05/31/12Methods of diminishing co-abuse potential
03/15/12Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
02/23/12Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/09/12Use of mirco-rna as a biomarker of immunomodulatory drug activity
02/02/12Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/12Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
Social Network Patent Pack
01/26/12Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/24/11Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/10/11Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/15/11Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
07/07/11Methods for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated
05/26/11Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
05/19/11Treatment using d-threo methylphenidate
05/05/11Methods for treating cutaneous lupus using aminoisoindoline compounds
03/17/11Methods for treating lymphomas in certain patient populations and screening patients for said therapy
02/17/11Method for treatment of macular degeneration using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
01/20/11Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/04/10Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
10/21/10N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
10/14/10Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
08/05/10Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
06/24/10Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
04/22/10Methods and compositions using immunomodulatory compounds for the treatment and management of cancers and other diseases
04/15/10Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
04/15/105-substituted quinazolinone derivatives and compositions comprising and methods of using the same
03/18/10Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
03/11/10Methods for treatment of colorectal cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
01/21/10Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same
11/19/09Isoindole-imide compounds, compositions, and uses thereof
07/23/09Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl))-piperidine-2,6-dione
06/18/09Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
06/11/09Isoindoline compounds and methods of making and using the same
06/11/09Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione)
06/04/09Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
04/02/09Methods for the treatment of scleroderma using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
04/02/09Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
Social Network Patent Pack
04/02/09Chronic, bolus adminstration of d-threo methylphenidate
03/26/09Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same
03/05/09Methods of diminishing co-abuse potential
03/05/09Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
01/21/10Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Celgene Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Celgene Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';